Safety and Efficacy Study of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults With Moderate or Severe Diabetic Foot Infections (DFI)
Latest Information Update: 27 Feb 2025
At a glance
- Drugs Contezolid (Primary) ; Contezolid-acefosamil (Primary) ; Linezolid; Linezolid
- Indications Diabetic foot
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors MicuRx Pharmaceuticals
Most Recent Events
- 25 Feb 2025 According to Shanghai MicuRx Pharmaceutical media release , Data Monitoring Committee has completed its first safety and efficacy assessment, confirming that the drugs safety and efficacy profiles meet favorable expectations and recommending the trial proceed as planned.
- 01 Nov 2024 Planned End Date changed from 1 Jun 2024 to 30 Jun 2026.
- 01 Nov 2024 Planned primary completion date changed from 1 Jun 2024 to 30 Jun 2026.